{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7fv9cJDA","lastupdate":"2023-09-18T00:00:00.000Z","update_date":"2023-09-18T00:00:00.000Z","lastModified":"Jul 21, 2025","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"escala-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$pmF4hLhJmEh1CQhEYliLlGII9d1Y1i1G3tYXXzGZlSD5kYUa7evimQ","name":"Escala Medical","oneliner":"Medical Device for Pelvic Organ Prolapse","registrar":"515158582","website":"https://escalamedical.com","careerspage":"","founded_month":12,"founded_year":2014,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCuvPMZfTPqgrnwGGwmdpr5w","facebook":"","linkedin":"https://www.linkedin.com/company/13184602","instagram":""},"social":["https://www.youtube.com/channel/UCuvPMZfTPqgrnwGGwmdpr5w","https://www.linkedin.com/company/13184602"],"flattenedsociallinks":"https://www.youtube.com/channel/UCuvPMZfTPqgrnwGGwmdpr5w|https://www.linkedin.com/company/13184602","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":12,"patent":1,"raised":8046000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Escala Medical is developing a nonsurgical, incision-free, mesh-free repair device to treat women with pelvic organ prolapse. The company’s transvaginal technology mirrors a surgery-based repair to fixate the vaginal apex to the sacrospinous ligament in a safe, quick outpatient procedure.\n\nThe device is a tissue-anchoring, approximation, and fixation system intended for anchoring sutures to ligaments of the pelvic floor. The device utilizes an incision-free vaginal approach enabling fixation of the vaginal apex to the sacrospinous ligament for apical suspension. Apical suspension is considered to be the most important component in prolapse repair, increasing the long-term success rates for the repair procedure.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972722607000","country":null,"address":{"israeli":[{"id":"5f3cd604-3f31-4daa-80ee-736e94c4044e","city":null,"type":null,"address":"Misgav, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"IK1aMOHdXpIOvuaDfp2ElEf6XPd5dUY4quEVa7lyLDONbvU5lFOCg3","date":"Jul 21, 2025","link":"https://www.calcalistech.com/ctechnews/article/sk6s7jnbxx","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"investment, expansion","round":"Series A","company":"Escala Medical","layoffs":null,"summary":"Escala Medical, a company specializing in innovative solutions for pelvic organ prolapse, has successfully completed a $4.5 million Series A funding round. The investment, co-financed by the European Innovation Council (EIC) Fund, will support the global expansion of Escalas FDA-approved Mendit device, which offers a minimally invasive alternative to traditional surgery. The funds will be used for commercial expansion in the U.S., market entry in Europe and Southeast Asia, and product enhancement. Escalas Mendit device has been approved in 48 hospitals in the U.S. and is anticipated to receive CE mark approval in 2026. The company aims to address the $7 billion global POP treatment market.","partners":["Singapore-based partner"],"customers":["hospitals","ambulatory surgery centers","private clinics"],"eventType":null,"investors":["European Innovation Council (EIC) Fund","The Trendlines Group","Consensus Business Group (CBG)","private investors in the United States and Israel"],"confidence":10,"key_topics":["funding","FDA approval","global expansion","womens health","innovation"],"date_of_event":"October 2023","product_stage":"released","investment_date":"October 2023","acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$4.5 million","structured_issues":["Investment","Customers","Partners","FDA approved","Expand"],"acquisition_amount":null,"FDA approved/pending approval":"approved","AI technology developing/using":"using","structuredIssuesShow":"#Investment  #Customers  #Partners  #FDA approved  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6DpB64ZpsTzPfiMoRs6HO6DgJEZ8G41GqYKO2itqEz8kgiObDth6Hp","news_summary":"Co-financed by the EIC Fund, the raise will support global expansion of Escala’s FDA-approved women’s health solution for pelvic organ prolapse.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"uikdzb7EPUOotInhpRIFWgVOOZBw31vknNZPENwNasZTAy7ugFWvcL","date":"Jun 26, 2023","link":"https://www.trendlines.com/news/escala-medical-awarded-e5-5-million-eic-funding-to-revolutionize-pelvic-organ-prolapse-treatment/","source":"www.trendlines.com","visible":1,"analysis":{"tags":"medical technology","company":"Escala Medical Ltd.","layoffs":null,"summary":"Escala Medical Ltd. has received a €5.5 million grant and equity investment from the European Innovation Council. The company offers an incision-free treatment for pelvic organ prolapse (POP), a condition that affects approximately 50% of women worldwide. Escalas breakthrough device, which is FDA-cleared and can be performed under local anesthesia in 5-8 minutes, addresses a significant market need. The funding from the EIC will support the companys operations expansion and help transform POP treatment for women globally. The investment validates Escalas technology and enhances its mission to provide durable, incisionless treatments for patients suffering from POP, improving their quality of life.","partners":null,"customers":null,"investors":"European Innovation Council","confidence":9,"key_topics":["Pelvic organ prolapse treatment","FDA clearance","EIC investment","Market need","Quality of life improvement"],"date_of_event":"19 December 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"€5.5 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uBqNwn2MYrMNxry1TQtPsC9ziyW4zFApYt7B0YjUHP1pqtYEBMPfhf","news_summary":"Escala Medical awarded €5.5 million EIC funding to revolutionize pelvic organ prolapse treatment - The Trendlines Group","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"62331106-60c7-4db5-b534-38cbe7bee4ba","date":"Apr 6, 2022","link":"https://www.prnewswire.com/il/news-releases/escala-medical-receives-fda-regulatory-clearance-301519125.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical device","company":"Escala Medical Ltd.","layoffs":null,"summary":"Escala Medical Ltd., a portfolio company of The Trendlines Group Ltd., has received regulatory clearance from the FDA for its first pelvic organ prolapse repair device. The company also completed a successful one-year follow-up on the first-in-human clinical study for the device. Pelvic organ prolapse affects nearly 50% of women worldwide, and Escalas incision-free repair solution aims to address this market need. The device allows for treatment at early stages of prolapse and can be performed in under 10 minutes. The company is positioning itself to introduce the device in the US market and has added Dr. Mickey Karram, an internationally renowned urogynecologist and pelvic surgeon, to its Scientific Advisory Board.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Clinical study","Pelvic organ prolapse repair device","FDA clearance","Incision-free procedure","New treatment paradigm"],"date_of_event":"April 6, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9Eklk46D9lmH9hGeceukk6U49Ku5R49hO9Hr3k9ANbNkYKK6qFluIa","news_summary":"Escala Medical Receives FDA Regulatory Clearance","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"51fc3839-9761-4b36-9f5c-139365a9bd69","date":"Jan 23, 2018","link":"https://www.israel21c.org/a-new-mesh-free-way-to-repair-pelvic-organ-prolapse/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"Medical Device, FDA Approval","company":"POP Medical Solutions","layoffs":"N/A","summary":"Israeli company POP Medical Solutions has introduced NeuGuide, a minimally invasive repair system for pelvic organ prolapse (POP), a condition that affects up to half of all women in their lifetime. The FDA-cleared device, which does not require dissection or mesh, elevates the uterus back to its normal position within minutes. The device was successfully tested on 15 women at Wolfson Medical Center in Israel, with 14 of the trial participants still doing well two years later. A multisite post-marketing study will soon be launched in the US, POP Medical’s first market.","partners":"Wolfson Medical Center, Soroka University Medical Center","customers":"Patients with Pelvic Organ Prolapse","investors":["RAD Biomed","Triventures","Israel Innovation Authority","Taiwan investors"],"confidence":9,"key_topics":["Pelvic Organ Prolapse","NeuGuide","Medical Device","Investment","Clinical Trials"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Investment","Customers"],"acquisition_amount":"N/A","structuredIssuesShow":"#Investment  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jBHDk9nKRdQggPet1r1sow3jGL1kRHpXyB7UqUKJGmqddqegXfPPXR","news_summary":"A new mesh-free way to repair pelvic organ prolapse","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"54df4050-7cef-4a32-9f27-ab92246e5e6c","date":"Jul 17, 2017","link":"http://www.hadassahmagazine.org/2017/07/17/can-stem-cells-fix-weakened-pelvic-floor/","source":"www.hadassahmagazine.org","visible":1,"analysis":{"tags":"Healthcare, Medical Innovation","company":"Escala Medical","layoffs":"Not mentioned","summary":"Dr. David Shveiky, a gynecologist at Hadassah-Hebrew University Medical Center, is exploring new treatments for pelvic organ prolapse, a condition that affects one in two women and is expected to increase by 50% by 2050. Current treatments include reconstructive surgery and synthetic grafting, but both have limitations and risks. Israeli startup Escala Medical has developed a vaginal anchor for milder cases, which is awaiting FDA approval. Dr. Shveiky is also investigating the use of stem cells to replace diseased or malfunctioning cells, which could provide a more effective treatment for pelvic organ dysfunction.","partners":"Hadassah-Hebrew University Medical Center","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":"Pelvic Organ Prolapse, Medical Innovation, Stem Cell Research, Surgical Mesh, Vaginal Anchor","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Investment, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6n7yLX2otf5K3hQRrpVqrg09e74PsOK7B61L2Xfxb83ordK5Z5QuLH","news_summary":"Can Stem Cells Fix a Weakened Pelvic Floor?  Hadassah Magazine","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7de626e0-212e-48df-9c2a-c8a1649c3d43","date":"Sep 25, 2016","link":"https://www.israel21c.org/first-ever-incision-free-fix-for-pelvic-organ-prolapse/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"Healthcare, Medical Device","company":"Escala Medical","layoffs":"Not mentioned","summary":"Israeli start-up Escala Medical is developing a non-surgical solution for pelvic organ prolapse, a condition affecting one in three women worldwide. The companys device, which is expected to be on the market by the end of 2017, offers a quick and safe alternative to surgery. The device is placed in the ligaments using a vaginal applicator, leaving two degradable sutures in the vagina. After several weeks of healing, the securing element falls out, leaving no device in place. The potential market for the device is estimated to be $600m in the US alone.","partners":"Not mentioned","customers":"Not mentioned","investors":"Trendlines Medical, Israel Innovation Authority","confidence":8,"key_topics":["Pelvic Organ Prolapse","Medical Device","Non-surgical Solution","Clinical Trial","Regulatory Approval"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hpso3vi4yi62C6N7gi3wiyBpebcjLiI6mMC75DYLj12W6D5MZbAbnp","news_summary":"First-ever incision-free fix for pelvic organ prolapse","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":6,"techcommunityinvolvement":null,"mediagallery":[{"id":"af201fe4-7fc6-4eed-afb6-1c34e68405e8","timestamp":"2020-06-14 14:37:16.000000","resources_type":2,"resources_title":"","resources_file_name":"r_livY0vlIQ","alt":"","imageurl":"https://img.youtube.com/vi/r_livY0vlIQ/0.jpg","url":"http://youtu.be/r_livY0vlIQ"},{"id":"2a0f1259-7585-4889-b8d9-a73de001d7d6","timestamp":"2019-09-17 11:09:08.000000","resources_type":2,"resources_title":"","resources_file_name":"neYQIa04qx4","alt":"","imageurl":"https://img.youtube.com/vi/neYQIa04qx4/0.jpg","url":"http://youtu.be/neYQIa04qx4"},{"id":"2a789de3-51fd-4f83-9b5c-d5fa204fd4dc","timestamp":"2019-09-17 11:08:55.000000","resources_type":2,"resources_title":"","resources_file_name":"ShqG0XO7XU4","alt":"","imageurl":"https://img.youtube.com/vi/ShqG0XO7XU4/0.jpg","url":"http://youtu.be/ShqG0XO7XU4"}],"tags":["gynecology","women-health","medical-devices","minimally-invasive","non-surgical","women","healthcare-providers","femtech"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Escala"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":3,"lastfunding":"$4.5M","totalrounds":4,"fundingstage":"A","totalfunding":"$8.05M","publicinvestors":3,"lastpublicfunding":4500000,"totalpublicrounds":4,"totalpublicfunding":8046000},"team":[{"name":"Edit  Goldberg","email":"edit@escalamedical.com","phone":"0544545276","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwKKv05MKDA","bounced":true,"claimed":0,"founder":0,"urlname":"edit-goldberg","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA4tK1iAoM","position":"CEO","last_name":"Goldberg","claimtoken":"o7Gj2sFGQSoJwpPBW6zuJba9xBmL0aDMZmxrJbsx5u7t5Exp2kTvoc","first_name":"Edit ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/edit-goldberg-54b0991/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-09-18 11:29:54.000000","initials":"EG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2019-09-17T00:00:00.000Z","crunchbaseid":"escala-medical","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-12-28T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"d13LTLDtMseb6kAB1ejv7EsWVFHKGQldx9eCuC3KO8E8Ba1Dxvo103","date":"Jul 2025","amount":"$4.5M","source":"https://www.calcalistech.com/ctechnews/article/sk6s7jnbxx","eventtype":"FundingRoundEvent","investment":[{"name":"EIC Accelerator","type":"Accelerator","amount":null,"hidden":true,"country":"Belgium","fullurl":"/program_page/eic-accelerator","logokey":null,"tagline":"EIC Accelerator is an accelerator managed by the European Innovation Council and European Commission (EC) based in Brussels, Belgium. The firm seeks to support small and medium enterprises.","urlname":"/program_page/eic-accelerator","isisraeli":0,"investorid":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","fundingtype":"General","leadpartner":null,"investmentid":"VI42tKx7rj1vHq2KTbkeiQHktTwxFynlAXZ5aTxUHUhc8Izd9KDO7t","fundingsubtype":"General","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/hubs-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":4500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"3sDLaXposSb334e7BBpU1xmfGGzRYoJLzNu9XJhEFQNc9Z1nlY1psh","hub":"EIC Accelerator","date":"Mar 2023","batch":"","amount":"Undisclosed","hub_id":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","source":"https://eic.ec.europa.eu/system/files/2023-06/EIC%20Accelerator-March%2022%202023%20Cut%20Off%20.pdf","enddate":"Mar 2023","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":true,"investment":[],"hub_fullurl":"/program_page/eic-accelerator","hub_logokey":null,"hub_urlname":"/program_page/eic-accelerator","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"/assets/empty-state.svg","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"EpWc78aVy14eMfFt1BjExfikPNvaVlRK0cp1b6n413CSHWUywgL0BQ","date":"Mar 2023","amount":"$3M","source":"https://www.trendlines.com/news/escala-medical-awarded-e5-5-million-eic-funding-to-revolutionize-pelvic-organ-prolapse-treatment/, https://eic.ec.europa.eu/system/files/2023-06/EIC%20Accelerator-March%2022%202023%20Cut%20Off%20.pdf","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"EIC Accelerator","type":"Accelerator","amount":null,"hidden":true,"country":"Belgium","fullurl":"/program_page/eic-accelerator","logokey":null,"tagline":"EIC Accelerator is an accelerator managed by the European Innovation Council and European Commission (EC) based in Brussels, Belgium. The firm seeks to support small and medium enterprises.","urlname":"/program_page/eic-accelerator","isisraeli":0,"investorid":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","fundingtype":"General","leadpartner":null,"investmentid":"odK9w1h0Y5SsPqEVa4gim6uNhPAnTs7cF3yQtwXnDew8FrZ3GEmyoJ","fundingsubtype":"General","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/hubs-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2prwCww","date":"Jan 2019","amount":"$546K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"ExitValley","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/exitvalley","logokey":"$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","tagline":null,"urlname":"/investor_page/exitvalley","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ2Kp4EKDA","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"2f34b800-408a-42a1-999c-2d2893ca78c9","fundingsubtype":"Equity Crowdfunding","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Equity crowdfunding","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":546000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8POyCgw","date":"","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"The Trendlines Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"2d876e70-c9af-4e08-8ba4-2c8d09eaf0b8","fundingsubtype":"Incubator","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/2014","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Escala Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$pmF4hLhJmEh1CQhEYliLlGII9d1Y1i1G3tYXXzGZlSD5kYUa7evimQ","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$pmF4hLhJmEh1CQhEYliLlGII9d1Y1i1G3tYXXzGZlSD5kYUa7evimQ","seoabout":"Escala Medical is developing a nonsurgical, incision-free, mesh-free repair device to treat women with pelvic organ prolapse. The company’s transvaginal te...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":1,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Women","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Women#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Women#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]},{"title":"Consumers","key":"0-1","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-1-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Women","key":"0-1-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Women"}]}]}],"coreTechnology":[]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Women","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":[],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Consumers","Demographics & Family","Women"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"d13LTLDtMseb6kAB1ejv7EsWVFHKGQldx9eCuC3KO8E8Ba1Dxvo103","date":"Jul 2025","amount":"$4.5M","source":"https://www.calcalistech.com/ctechnews/article/sk6s7jnbxx","eventtype":"FundingRoundEvent","investment":[{"name":"EIC Accelerator","type":"Accelerator","amount":null,"hidden":true,"country":"Belgium","fullurl":"/program_page/eic-accelerator","logokey":null,"tagline":"EIC Accelerator is an accelerator managed by the European Innovation Council and European Commission (EC) based in Brussels, Belgium. The firm seeks to support small and medium enterprises.","urlname":"/program_page/eic-accelerator","isisraeli":0,"investorid":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","fundingtype":"General","leadpartner":null,"investmentid":"VI42tKx7rj1vHq2KTbkeiQHktTwxFynlAXZ5aTxUHUhc8Izd9KDO7t","fundingsubtype":"General","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/hubs-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":4500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2prwCww","date":"Jan 2019","amount":"$546K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"ExitValley","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/exitvalley","logokey":"$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","tagline":null,"urlname":"/investor_page/exitvalley","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ2Kp4EKDA","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"2f34b800-408a-42a1-999c-2d2893ca78c9","fundingsubtype":"Equity Crowdfunding","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Equity crowdfunding","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":546000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8POyCgw","date":"","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"The Trendlines Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"2d876e70-c9af-4e08-8ba4-2c8d09eaf0b8","fundingsubtype":"Incubator","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"EpWc78aVy14eMfFt1BjExfikPNvaVlRK0cp1b6n413CSHWUywgL0BQ","date":"Mar 2023","amount":"$3M","source":"https://www.trendlines.com/news/escala-medical-awarded-e5-5-million-eic-funding-to-revolutionize-pelvic-organ-prolapse-treatment/, https://eic.ec.europa.eu/system/files/2023-06/EIC%20Accelerator-March%2022%202023%20Cut%20Off%20.pdf","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"EIC Accelerator","type":"Accelerator","amount":null,"hidden":true,"country":"Belgium","fullurl":"/program_page/eic-accelerator","logokey":null,"tagline":"EIC Accelerator is an accelerator managed by the European Innovation Council and European Commission (EC) based in Brussels, Belgium. The firm seeks to support small and medium enterprises.","urlname":"/program_page/eic-accelerator","isisraeli":0,"investorid":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","fundingtype":"General","leadpartner":null,"investmentid":"odK9w1h0Y5SsPqEVa4gim6uNhPAnTs7cF3yQtwXnDew8FrZ3GEmyoJ","fundingsubtype":"General","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/hubs-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}